petronella Kettunen

ͼƬ:petronella Kettunen

½üÄêÀ´£¬Æ¤ÖÊÏÂСѪ¹Ü¼²²¡ÒѳÉΪԽÀ´Ô½³£¼ûµÄÈÏÖªÕï¶Ï¡£¸çµÂ±¤´óѧ(University of Gothenburg)µÄÑо¿ÈËÔ±ÏÖÔÚÒѾ­Ö¤Ã÷£¬Í¨¹ý½áºÏ¼¹ËèÒººÍѪҺÖвâÁ¿µÄÁ½ÖÖÉúÎï±êÖ¾ÎÓпÉÄÜʶ±ð³ö»¼ÓÐÕâÖÖ¼²²¡µÄ»¼Õߣ¬ÕâÔö¼ÓÁËÖÎÁƺÍÒ©Î↑·¢µÄDZÁ¦¡£

Ƥ²ãÏÂСѪ¹Ü¼²²¡ÊÇÒ»ÖÖ×î³£¼ûµÄÈÏÖª¼²²¡£¬Óë°¢¶û´Äº£Ä¬²¡ºÍ»ìºÏÐÔ³Õ´ôÒ»Æð£¬ºóÕßÊÇÒ»ÖÖ°¢¶û´Äº£Ä¬²¡Óë´óÄÔѪ¹ÜËðÉËÒ»Æð·¢ÉúµÄÐÎʽ¡£

petronella KettunenÊǸçµÂ±¤´óѧÉñ¾­ÉúÎïѧ¸±½ÌÊÚ£¬Ò²ÊǸçµÂ±¤Çá¶ÈÈÏÖªÕϰ­Ñо¿µÄÏîÄ¿¾­Àí£¬ËûÊÇÕâÆªÎÄÕµÄÖ÷Òª×÷Õß:

¡°µ½Ä¿Ç°ÎªÖ¹£¬ÎÒÃÇ»¹Ã»ÓÐÆ¤ÖÊÏÂСѪ¹Ü¼²²¡µÄ±ê¼ÇÎÕâÒâζ×ÅÕâÖÖ¼²²¡²»ÄÜͨ¹ý¼ì²â¼¹ËèÒº»òѪҺÑù±¾À´ÇáÒ×ʶ±ð¡£ÎÒÃÇÏÖÔÚ¿ª±ÙÁËÒ»¸ö·¢ÏÖÕâÖÖ¼²²¡µÄ»ú»á£¬Äܹ»Í¨¹ý¸Ä±äÉú»î·½Ê½ºÍ·þÓýµÑ¹Ò©À´°ïÖúÕâÒ»»¼ÕßȺÌå¡£¡±Ëý˵¡£

ÔÚÕâÏîÑо¿ÖУ¬¸çµÂ±¤´óѧ(University of Gothenburg)µÄÑо¿ÈËÔ±¼ì²âÁ˼¹ËèÒººÍѪҺÑù±¾ÖеöÉúÎï±ê¼ÇÎ¿´¿´ËüÃÇÊÇ·ñ¿ÉÒÔÓÃÀ´Çø·ÖÕâÈýÖÖ³£¼ûµÄÈÏÖª¼²²¡¡£°üÀ¨¶ÔÕÕ×éÔÚÄÚ£¬¹²ÓÐ170Ãû»¼Õß±»ÄÉÈëÑо¿¡£

¼ø±ðƤÖÊÏÂСѪ¹Ü¼²²¡

¸ÃÑо¿Ö¤Êµ£¬»ùÓÚ¼¹ËèÒººÍѪҺÖе°°×°×µ°°×µÄ±ÈÀý£¬Ñª¹ÜËðÉ˵ÄÉúÎï±êÖ¾ÎïÔÚÆ¤ÖÊÏÂСѪ¹Ü¼²²¡»¼ÕßÖÐÏÔÖø¸ü¸ß¡£¸ÃÑо¿»¹Ìá³öÁËÒ»ÖÖеÄÉúÎï±êÖ¾Î¼´¼¹ËèÒºÖеí·ÛÑùǰÌåµ°°×(App)µÄƬ¶Î£¬ÕâÖÖ±êÖ¾ÎïÔÚÆ¤ÖÊÏÂСѪ¹Ü¼²²¡»¼ÕßÖнϵÍ¡£

Kettunen˵:¡°µ±ÎÒÃǽ«Ñª¹ÜËðÉ˵ÄÉúÎï±êÖ¾ÎïÓëÎÒÃÇʶ±ðµÄµ°°×ÖÊÆ¬¶ÎÏà½áºÏʱ£¬½«Æ¤ÖÊÏÂСѪ¹Ü¼²²¡»¼ÕßÓë¶ÔÕÕ×é¡¢°¢¶û´Äº£Ä¬²¡»¼ÕߺͻìºÏÐÔ³Õ´ô»¼Õß·ÖÀ뿪À´µÄ¿ÉÄÜÐԵõ½Á˸ÄÉÆ¡£¡±

¶¨ÒåÁ¼ºÃµÄÑо¿»ù´¡

ÕâÒ»·¢ÏÖÒ²Ìá¸ßÁËÔÚÐÂÒ©ÁÙ´²ÊÔÑéÖÐϸ»¯»¼Õß¶ÓÁеĿÉÄÜÐÔ¡£Õï¶Ï»¼ÓÐÕâЩ¼²²¡µÄ»¼Õß¶ÔÓÚÈ·¶¨Ã¿ÖÖ¼²²¡µÄÕýÈ·»¼ÕßȺÌå·Ç³£ÖØÒª£¬Õâ·´¹ýÀ´ÓÖÓÐÖúÓÚδÀ´µÄÖÎÁÆÑо¿¡£

¡°ÀýÈ磬¶ÔÓÚ°¢¶û´Äº£Ä¬ÊÏÖ¢µÄÖÎÁÆÑо¿£¬ÄãÐèÒªÖªµÀËùÓл¼Õß¶¼»¼Óа¢¶û´Äº£Ä¬ÊÏÖ¢£¬¶ø²»ÊÇÆäËûÈÏÖª¼²²¡£¬·ñÔò½á¹û½«²»×¼È·¡£¡±

°¢¶û´Äº£Ä¬ÊÏÖ¢ºÍƤÖÊÏÂСѪ¹Ü¼²²¡

°¢¶û´Äº£Ä¬²¡ÊÇÖð½¥·¢Õ¹µÄ¡£ÔÚÆä·¢Õ¹ÔçÆÚ£¬ÕâÖÖ¼²²¡Í¨³£»áµ¼Ö¼ÇÒäɥʧ£¬ÒòΪ¸ºÔðÕâÒ»¹¦ÄܵĴóÄÔÇøÓò±»ÆÆ»µÁË¡£

Ïà·´£¬Æ¤ÖÊÏÂСѪ¹Ü¼²²¡Ó°Ïì´óÄÔÉî´¦£¬´óÄÔÆ¤²ãÒÔϵÄѪ¹Ü£¬Ê¹ÈÏÖªÖ¢×´²»Í¬¡£ÔÚ¼ÇÒäÁ¦Ã÷ÏÔ¼õÍË֮ǰ£¬»¼ÕßÍùÍù»á³öÏÖͻȻµÄÈ˸ñ±ä»¯ºÍ¾«ÉñÃôÈñ¶ÈϽµ¡£

СѪ¹Ü²¡±ä¿É°éÓиßѪѹ£¬»¼Õß³£±íÏÖΪÄÔ°×ÖÊС¹£ËÀµÈѪ¹ÜËðÉË¡£Æ¤ÖÊÏÂСѪ¹Ü²¡±äÔÚѪ¹ÜÐÔÈÏÖª¼²²¡×éÖÐÕ¼ºÜ´ó±ÈÀý¡£

Ñо¿½á¹û·¢±íÔÚÃÀ¹ú°¢¶û´Äº£Ä¬ÊÏ֢Э»áµÄ¿ÆÑ§ÔÓÖ¾¡¶°¢¶û´Äº£Ä¬ÊÏÖ¢Óë³Õ´ô:Õï¶Ï¡¢ÆÀ¹ÀÓë¼²²¡¼à²â¡·ÉÏ¡£

ÎÄÕ±êÌâ

Blood-brain barrier dysfunction and reduced cerebrospinal fluid levels of soluble amyloid precursor protein-¦Â in patients with subcortical small-vessel disease